Skip to main content
. 2012 May 8;26(6):1056–1073. doi: 10.1210/me.2011-1258

Table 3.

GH-stimulated phosphosites identified by phosphoproteomics that are predicted4 to be phosphorylated by Akt/PKA

Gene Protein Phosphosite5 Ratio (+GH/−GH) (5a/5b/15 min)6
Acly ATP citrate lyase (ACLY) Ser455 1.5/−/−
Akt1s1 Proline-rich AKT1 substrate 1 (PRAS40) Thr247 3.8/−/−
Bcl9l B-cell CLL/lymphoma 9-like protein Ser118 −/2.4/−
Dact3 Dapper homolog 3 Ser409 2.2/−/−
Eif4b Eukaryotic translation initiation factor 4B (eIF4B) Thr420 −/3.1/−
Flnc Filamin-C Ser2234 3.3/2.3/1.7
Ndrg1 N-myc downstream-regulated gene 1 protein (NDRG1) Thr328 −/1.8/−
Ndrg1 N-myc downstream-regulated gene 1 protein (NDRG1) Thr330 −/1.5/−
Zc3hc1 Nuclear-interacting partner of anaplastic lymphoma kinase (Nipa) Ser406 −/2.6/−
Pdcd4 Programmed cell death protein 4 Ser457 −/3.8/−
Plec1 Plectin-1 Ser4391 (Ser4243) −/2.1/−
Plec1 Plectin-1 Ser4393 (Ser4245) 1.6/2.1/−
Ranbp3 Ran-binding protein 3 Ser58 −/2.5/−
Slc9a1 Sodium/hydrogen exchanger 1 (NHE1) Ser707 −/7.3/3.3
Tns3 Tensin-3 Ser769 2.0/−/−
4

GH-dependent phosphopeptides identified during the SILAC-based phosphoproteomics screens were analyzed by MaxQuant to predict phosphosites with best-fit motif consistent with phosphorylation by Akt.

5

Numbering is according to PhosphositePlus (http://www.phosphosite.org). Numbering in parentheses is according to MaxQuant.

6

5a and 5b refer to the first and second 5 min trials, respectively.